CD274 and neoplasm: To examine the changes of tumor-infiltrating lymphocytes and immune cells in tumor dLNs, we harvested tumor tissue and the dLNs of all tumor-bearing mice after three doses of treatment with isotype IgG, anti-TNFR2, anti-PD-L1, or the combination.